Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Elkhorn Partners Raises Position in Orbit International to 22.4%

Elkhorn Partners, Orbit International Corporation: Elkhorn Partners Limited Partnership, just now, reported boosting its position in Orbit International Corp. (NASDAQ:ORBT) to 22.4% of the company’s common stock. Elkhorn increased its exposure in Orbit International to around 1.02 million shares, compared to some 959,500 shares disclosed in its latest 13F.

Orbit International Corporation

At the current stock price of the company, the value of the position held by Elkhorn amounts to approximately $3.4 million.

Orbit International is engaged in the production of a variety of electrical components, conducting its operations through its division, Orbit Instrument, and several wholly-owned subsidiaries. Net earnings of the company halved in year-on year terms to $0.02 per diluted share in the second quarter of 2013.

Grt Capital Partners, led by Gregory Fraser, Rudolph Kluiber, and Timothy Kroch, and Jim Simons‘s Renaissance Technologies reported owning 26,105 shares, and 21,000 shares respectively at the end of the second quarter.

Disclosure: none

Recommended Reading:

Railroad Stocks Are Warren Buffett’s Favorite Indicator, and They’re Booming

Soroban Capital Boosts Position in Coca-Cola Enterprises to 6.3%

Polar Capital Lowers Stake in Somero Enterprises

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!